Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-22-000114

Options or other derivatives

  • Chief Scientific Officer acquired 157,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carter Laura Chief Scientific Officer 2022-12-07 Grant or award · Stock Option (Right to Buy) +157,500 157,500 D
Loading xslF345X03/wf-form4_167062448909309.xml…